News

2018

company

year

domain

Rubius Therapeutics, Inc. Secures $75 Million Loan Facility

12.21.2018

Flagship-backed Foghorn Woos Bristol-Myers vet Carl Decicco to Direct its ‘Gene Traffic Control’ Platform

Foghorn Therapeutics 12.13.2018

Foghorn® Therapeutics Appoints Carl P. Decicco, Ph.D. as Chief Scientific Officer

Foghorn Therapeutics, Flagship Pioneering 12.13.2018

Indigo Ag, Inc. Acquires TellusLabs, a Leader in Satellite Technology and Artificial Intelligence, to Enhance Indigo’s Data-Driven Agronomic Solutions

Indigo Agriculture 12.13.2018

A Designer Seed Company is Building a Farming Panopticon

Indigo Agriculture 12.13.2018

Denali Therapeutics Announces First Patient Dosed In Phase 1b Study Of DNL201 For Parkinson’s Disease

Denali Therapeutics 12.10.2018

Evelo Enters into Clinical Trial Collaboration Agreement with Merck

Evelo Biosciences 11.27.2018

Evelo Biosciences Announces First Dosing in Phase 1b Clinical Trial of EDP1815 in Psoriasis and Atopic Dermatitis

Evelo Biosciences 11.26.2018

Massachusetts Doctors Going the Startup Route

Flagship Pioneering 11.26.2018

Denali Therapeutics Announces Positive Clinical Results With Its Lead RIPK1 Inhibitor Molecule And Intention To Initiate Patient Studies In Multiple Indications In Collaboration With Sanofi

Denali Therapeutics 11.19.2018

Loading